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Basic renal function tests such as maximum urine osmolality and urinary elimination of
albumin and N-acetyl-glucosaminidase often reveal abnormalities in clinical cases involving
hyperpressure in the urinary tract or loss of renal parenchyma. However, in all the available
algorithms dedicated to the study of children with urinary tract infection or dilation, the
beneﬁt of using these functional parameters is not mentioned. In this review, we  provide
information about the practical usefulness of assessing the basic renal function parameters.
From these data, we propose an algorithm that combines morphological and functional
parameters to make a reasoned case for voiding cystourethrography.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Utilidad  de  las  pruebas  básicas  de  estudio  de  la  función  renal  en  la  toma
de  decisiones  en  nin˜os  con  pérdida  de  parénquima  renal  o  dilatación  de
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y  la eliminación urinaria de albúmina y de N-acetil-glucosaminidasa se alteran con mucha
frecuencia en situaciones clínicas que cursan con hiperpresión en la vía urinaria o con
pérdida de parénquima renal. No obstante, en todos los algoritmos que se pueden consultar
dedicados al estudio de los nin˜os con infección urinaria o dilatación de la vía urinaria nunca
se  menciona el beneﬁcio del uso de esos parámetros funcionales. En esta revisión, ofrecemos
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información acerca de la utilidad práctica que conlleva la determinación de los parámetros
básicos de estudio de la función renal. A partir de esos datos proponemos un algoritmo
destinado a realizar una petición razonada de la cistografía conjuntando parámetros mor-
fológicos y funcionales.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/
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sion of urine during water restriction and observed that in
patients with terminal uraemia the osmotic pressure of urine
hardly changed and was signiﬁcantly closer to the value for“The truth that seems hardest is but a kernel of another, more
complete, truth, but it is never fully complete; and only thus can
it be interpreted and judged.”
(Gregorio Maran˜ón y Posadillo, 1887–1960)
In paediatric practice there are two very common sit-
ations in which it becomes necessary to make decisions
egarding the morphological tests that we should use in young
atients. We  refer to urinary tract infections (UTI) and congen-
tal anomalies of the kidney and urinary tract (CAKUT) that
re all too often detected on ultrasounds performed in utero.
n many  cases, both situations occur simultaneously.
In the context of UTIs, speciﬁcally, the indication criteria for
he tests to be performed have varied widely over time. Since
esicoureteral reﬂux (VUR) is a common ﬁnding in patients
ith UTI, the idea that it played a role in its pathogenesis
as soon established, and so cystography was indicated and
s still performed in many  communities when facing a ﬁrst
nfection. In addition, the idea that VUR was the cause of
enal scarring resulting in the intiation chronic kidney failure,
as cemented. It is from this that the term “reﬂux nephropa-
hy” was coined, which has now fortunately been replaced
y “nefropatía cicatricial [scarring nephropathy]” in Spanish.
his “fear” of not diagnosing VUR early enough to prevent
ts potential complications ended up developing into a view
hat has been called the “reﬂux-centric” paradigm.1 Luckily
his notion has been changing in recent years towards more
autious approaches.2,3
In all the algorithms dedicated to evaluation of children
ith UTI or CAKUT that can be consulted, kidney function
arameters never appear among the variables or conditions
hat lead to ordering imaging test .4–6 This even happens in the
lgorithms designed by nephrologists. In this review, we offer
nformation about the utility of basic kidney function tests
n the management of children with UTI and CAKUT. Specif-
cally, we  will refer to testing the kidneys’ ability to manage
ater (maximum urine osmolality) and urinary elimination
f albumin and N-acetyl-glucosaminidase (NAG).
verview:  on  renal  concentrating  capacity,
lbuminuria,  and  N-acetyl-glucosaminidase
he history of testing the kidneys’ ability to ﬁnely adjust
he body’s water metabolism using urine concentration and
ilution mechanisms goes back more  than one and a half cen-
uries. In 1859, Hoppe-Seyler (1825–1895) (Fig. 1), a German
hysiologist and chemist, demonstrated that when urine and
erum from the same animal were separated by a membrane
rom a pig bladder, the ﬂow direction was from the plasmaby-nc-nd/4.0/).
towards the urine.7 As a result, he had discovered that urine
could be more  concentrated that the glomerular ultraﬁltrate.
Years later in Tübingen in 1892, Dreser (1860–1925) studied the
physiology of water excretion. He established that the freez-
ing point depression of blood determined cryoscopy (−0.56 ◦C)
was not altered by water intake, in contrast to what happens
with urine. During water restriction, Dreser demonstrated that
the freezing point of urine decreased −2.40 ◦C in humans, in
other words, the osmotic pressure of urine may be higher than
that of plasma.8 In a patient with diabetes insipidus, the freez-
ing point of urine was only −0.20 ◦C; as described by Richet,
probably the ﬁrst ever use of cryoscopy in a patient.9 Shortly
afterwards in Paris, Winter determined the freezing point of
many ﬂuids and conﬁrmed Dreser’s ﬁndings.10
Later, the Hungarian doctor Korányi (1866–1944) supposed
that the kidneys regulate the osmotic pressure of urine so
that the osmotic pressure of blood remains constant. To do
this, he studied the changes in the freezing point depres-Fig. 1 – Felix Hoppe-Seyler (1825–1895).
224  n e f r o l o g i a. 2 0 1 6;3 6(3):222–231
Fig. 2 – Joaquín Albarrán (1860–1912).
Fig. 3 – Joaquín Albarrán’s “experimental polyuria” test. In
the presence of a water stimulus, the healthy kidney (rein
sain) adapts by increasing the volume of urine and the
14
21,22plasma.9,11 He called this situation isostenuria. Based on these
ﬁndings, he was the ﬁrst to introduce the functional concept
of renal insufﬁciency.12 It should therefore be noted that this
very familiar term for current nephrologists arose from the
study of the kidneys’ ability to manage water.
Albarrán (1860–1912) (Fig. 2) was a Cuban urologist who
studied medicine in Barcelona. In 1878 he moved to Paris
where he worked with the anatomist Ranvier (1835–1922)
and the urologist Guyon (1831–1920). Albarrán was respon-
sible for a basic and little known discovery. At a time when
the only known imaging test was the recently discovered
X-ray, he could discern which kidney was diseased in the
case of unilateral lesions potentially requiring surgery, such
as, for example, in renal tuberculosis. To do this, he created
the so-called “Albarran lever”, a small addition to the cysto-
scope through which he could direct a catheter towards to
the ureteral meatus to directly collect urine coming from each
kidney.13 Afterwards, he created one of the ﬁrst stimulus func-
tion tests, the “experimental polyuria” test. In the presence of
a water stimulus, the healthy kidney adapted to the stimu-
lus and the disease one did not14 (Fig. 3). His book, Exploration
des functions rénales,  written in 1905 is, surely, the ﬁrst in his-
tory on the topic and a historical debt held collectively by
nephrologists.14diseased kidney (rein malade) does not. .
In 1909, Ambard and Papin laid out the concept of maxi-
mum concentration, thus providing all the elements for a new
function assessment index. At that time it was known that,
even during periods of severe dehydration, urine continued to
be formed. It is what came to be called the “obligatory urine”
of Ambard and Papin.15
Soon tests were designed to stimulate the maximum urine
concentrating capacity by restricting liquids, such as the tests
by Volhard16 and Addis and Schevky,17 in which the osmotic
pressure of urine was no longer determined but rather its
density (speciﬁc gravity). In any case, with these tests the pro-
duction of endogenous ADH was stimulated. Decades later,
the so-called “dry diet” test would also become standard in
children starting at 2 years of age, although it measured uri-
nary osmolality.18
Starting in the 1910s, information about how the pituitary
gland regulates water excretion through the kidneys began to
be available.19 Soon it could be demonstrated that the poste-
rior portion of this gland produced an antidiuretic substance
that behaves like an “authentic” hormone by passing through
circulation and acting on the kidney.20 Subsequently, pituitary
extracts started to be used to determine maximum urinary
osmolality.
In 1968, a synthetic analogue of vasopressin, desmopressin,
became available23 and concentration test could be conducted
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Fig. 4 – Simpliﬁed model of the urine concentrating mechanism. To create a hypertonic medullary interstitium, adequate
function of all the tubular sodium transporters is necessary, for example, NHE3 (type 3 Na+/H+ exchanger), NaPi-2, (type 2
Na-Pi cotransporter),  BSC-1 (type 1 bumetanide-sensitive Na-K-2Cl cotransporter),  or TSC (thiazide-sensitive cotransporter)  in the
lumen side of the tubule (mechanism 1). A defect in its function would cause a loss of saline with an accompanied loss of
water that would cause a less hypertonic medullary interstitium. Furthermore, adequate function of the urea transporters
(UT-A1, UT-A2, UT-A3) is necessary to increase the medullary interstitium osmolality (mechanism 2). In the presence of this
hypertonic medullary interstitium, vasopressin can concentrate the urine thanks to the stimulus it exercises on the
aquaporins (AQP), which enables the tubular lumen content to become equilibrated with the hypertonic medullar
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ore  comfortably and in less time since it had a greater antid-
uretic effect than the natural hormone.24
It is outside the scope of this review to discuss the anatomic
nd functional complexity of the kidney’s urine concentrat-
ng mechanism, the details of which have been coming to
ight, as indicated above, for more  than a century and a half
ith key moments such as understanding the countercurrent
echanism25 or the discovery of aquaporins.26
Remember that the renal concentrating capacity depends
n an adequate glomerular ultraﬁltrate supply to the tubules,
 hypertonic medullary interstitium, a structurally intact
edullary countercurrent mechanism,25 and normal water
ermeability of the tubules in response to vasopressin. The
oncentrating capacity is dependent on the renal medulla.27
he degree of medullary concentration is established primor-
ially by the renal tubules in the loop of Henle and the blood
essels surrounding it (vasa recta) during the countercurrent
xchange process. The purpose of this mechanism is to cre-
te a hypertonic medullar interstitium.25 In this hypertonicinterstitium, vasopressin can concentrate the urine through
a passive water equilibrium mechanism in the main cells of
the collecting ducts, which allows the tubular lumen contents
to equilibrate with the hypertonic medullary interstitium.28
Vasopressin secretion in response to water restriction causes
the intracellular aquaporin-2 vesicles (AQP2) to relocate in the
apical membrane of the main collecting duct cells. This shift
allows water to be reabsorbed from the tubular lumen into the
cell and, therefore, concentration of the ﬁnal urine29 (Fig. 4).
The introduction of albuminuria and NAG determination
in clinical practice is much more  recent. Nevertheless, ﬁnding
proteinuria was one of the ﬁrst kidney function tests dis-
covered in history., In 1764 Cotugno (1736–1822) described
a typical case of acute nephritis with anasarca and large
quantities of a heat-coagulable substance ovi albumini persim-
ilem in the urine.30 His ﬁndings were conﬁrmed years later
by the English physician Blackall (1771–1860). Nevertheless,
at the end of the 1980s, suitable techniques were available
that enabled small quantities of albumin to be measured
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that were not measurable with earlier techniques. The term
microalbuminuria has been widely used to refer to it, despite
being incorrect from a semantic point of view. Therefore it is
better to simply use the name albuminuria. It was initially
used in clinical practice to try to detect incipient diabetic
nephropathy.31 Since then it has been demonstrated that
continued elevated excretion is an early sign of glomerular
damage in processes that occur with hyperﬁltration, both in
cases in which the patients had all their nephrons (diabetic
nephropathy32, obesity33) as well as in those where there is
loss of parenchyma.34 Later it was demonstrated that it is
also a good predictor of developing cardiovascular disease.35
In children, it has been observed that it can be elevated in
cases of VUR.36,37 One unknown question is if this increase is
due to the parenchymal loss that may exist in some VUR cases
(renal dysplasia, scarring) or to the elevated pressure of VUR
on the urinary tract.
Since the 1960s it has been known that NAG is an enzyme
present in kidney tissues,38 in the lysosomes of the proximal
tubular cells, and that its excretion in urine increases when
cells are damaged and NAG is releases into the tubular lumen
.39 Classically, the determination of NAG was used to evalu-
ate the nephrotoxicity caused by aminoglycoside antibiotics.40
Moreover, NAG levels may be increased in cases of elevated
intratubular pressure as in urinary tract obstruction41 and in
VUR, although in this case, as occurs with albuminuria, it is
difﬁcult to know if it is due to the elevated pressure or to the
associated reduction of glomerular ﬁltration.36
On  basic  determinations  of  kidney  function  as
markers  of  parenchyma  loss
In a study including 77 children with normal renal
parenchyma as conﬁrmed by dimercaptosuccinic acid scan
and 102 children with loss of parenchyma (one or more  scars,
single kidney, hypodysplasia), we  determined the quality and
diagnostic efﬁciency of the kidney function markers listed
above. The sensitivity of maximum urine osmolality was 30.4%
for detecting loss of parenchyma (84.8% speciﬁcity), 15.6%
for urinary albumin excretion (92.1% speciﬁcity), 11.5% for
NAG/creatinine ratio (100% speciﬁcity), and 8.9% for glomeru-
lar ﬁltration rate (GFR) (100% speciﬁcity). However, it is striking
that higher sensitivity (37.9%) was observed with urine volume
corrected for 100 ml  of GFR. This ﬁnding demonstrates how
this parameter that is rarely used, but is easy to calculate,
(plasma creatinine × 100/urine creatine) can be very useful
in daily practice. In any case, it was demonstrated that the
parameters that reﬂects the kidneys’ ability to manage water
are the most sensitive for detecting loss of parenchyma.42 As
a corollary to this study, we  can emphasize that GFR was the
least sensitive parameter and that the sensitivity reached with
the parameters studying the kidneys’ ability to manage water
was very low;  therefore, currently we  do not have methods
that can adequately assess a modest nephron loss.
In 2008, in a study including data from 160 children with
UTI or CAKUT, we  proved that, in those with a normal max-
imum urine osmolality, the GFR was always normal while
all patients with a reduced GFR had an altered concentrat-
ing capacity.43 In that study, the GFR was calculated with the;3 6(3):222–231
classic Schwartz formula that uses a constant value of 0.55,
which now we recognize that it overestimates GFR. In a recent
review using the new formulas to calculate the GFR including
cystatin C that are more  accurate,44 we observed that a few
children in stage G2 chronic kidney disease still concentrate
well (near the lower limit of normality), but they are the excep-
tion that conﬁrm the rule (data not published). In daily practice
with our young patients if the maximum urine osmolality is
normal we do not draw blood to conﬁrm a normal GFR.
As is known, in the Clinical Practice Guideline for the Eval-
uation and Management of Chronic Kidney Disease 2012 (KDIGO
Guidelines), stage G1 of chronic kidney disease is deﬁned by
the presence of abnormalities of kidney structure or function,
present for at least 3 months and not accompanied by GFR
deterioration.45 Interestedly, the authors of the guidelines,
among other functional alterations, included increased albu-
minuria but did not mention changes in the kidney’s ability to
manage water. In a recent study, we studied 116 children with
an abnormal dimercaptosuccinic acid scan.46 Among the 100
children in stage G1 included, the frequency of a concentrating
capacity defect (29%) and increased urine volume (20%) was
higher than that of an increase in albuminuria (12%) and uri-
nary excretion of NAG (3%). All the included children in stages
G2-G5 had alterations in the kidneys’ ability to manage water.
Furthermore, a direct correlation was observed between the
GFR calculated with the 2012 CKID Schwartz formula47 and the
maximum urine osmolality (r = 0.63; p < 0.001) (Fig. 5b).
All the data listed in this section coincide with what
Korányi began to glimpse a century ago9,11,12 and with what
was conﬁrmed by both Alving and van Slyke in 193448 (Fig. 5a)
and Epstein in 1966.49 In the words of this last author: “The
ability of the kidneys to excrete a concentrated urine is
impaired together with other renal functions whenever the
kidneys are progressively scarred and the amount of function-
ing renal parenchyma is diminished. Concentrating capacity
and glomerular ﬁltration rate are therefore reduced roughly in
parallel in many  common diseases which cause widespread
scarring of the kidneys”.49
On  basic  determinations  of  kidney  function  as
markers  of  elevated  pressure  on  the  renal
parenchyma
The results obtained in the experimental models that cause
elevated pressure in the urinary tract are difﬁcult to extrap-
olate to malformations that occur with hydronephrosis in
humans, for two reasons. The ﬁrst is that in both VUR and
uteropelvic junction (UPJ) obstruction there may be an asso-
ciated glomerular loss (renal dysplasia, scarring). The second
is that in mild or moderate VUR the elevated pressure can
be intermittent and in UPJ obstruction the pressure may vary
extensively according to the degree of obstruction in the utero-
pelvic junction.
The authors’ concern about the presence of functional
lesion in cases of hydronephrosis come from the past.50In the 1960s it was demonstrated that an experimental
ureteral obstruction produced an impairment in concentrat-
ing capacity.51 The possibility of using desmopressin allowed
the determination maximum urine osmolality that was
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hn both ﬁgures the points are more  dispersed in cases with n
educed in both adults52,53 and children with hydronephrosis
nd particularly in cases of UPJ obstruction.54,55 In addition,
n association between VUR and a defect in concentrating
apacity been frequentlydescribed.56–61
In recent years, there has been studies to identify the mech-
nisms that enable the kidney to handle water in situations
f elevated pressure. Thus, it has been observed that uri-
ary obstruction causes a reduction in: the activity of some
odium transporters in the tubules62–64 (mechanism 1, Fig. 4),
he expression of the urea transporters65 (mechanism 2, Fig. 4),
nd in the activity of the aquaporins expressed in the collect-
ng duct64,66 (mechanism 3, Fig. 4). All these changes cause
olyuria and renal salt losses.
An increase in urine excretion of albumin has been
escribed in both UPJ obstruction67 and VUR.36,37,68 Elevated
xcretion of NAG and other proteins, are markers of proximal
ubule injury, have been shown in both circumstances, UPJ
bstruction41,69,70 and VUR.36,71–73
In paediatric medicine there are cases of urinary tract dila-
ion that are not secondary to VUR or to obstruction and there
s evidenced elevated pressure in the urinary tract. For the
ases in which the diameter of the renal pelvis is greater
han 2 cm and there is no elevated pressure, the term “pri-
ary  hydronephrosis” has been used, and if the ureter is also
ilated the expression “non-obstructive megaureter” has been
sed. So, in a study including 38 children with a pelvic diam-
ter greater than 2 cm,  we studied if there were differences
n the kidney function in the different types morphological
bnormalities.74 Maximum urine osmolality was reduced in
00% of the VUR cases, in 75% of the UPJ obstruction cases, and
n only 16.7% of the primary hydronephrosis cases. Albumin
xcretion in urine was increased in 62.5% of VUR cases and
n only 8.3% of UPJ obstruction cases, and in 11.1% of primary
ydronephrosis cases. In turn, NAG excretion was elevated in
2.8% of VUR cases, in 25% of UPJ obstruction cases, and in
.7% of cases of primary hydronephrosis. Thus they observed
ow it is the most sensitive concentrating test for detectingal GFR than when the kidney disease is advanced.
alterations in kidney function in cases of hydronephrosis. Fur-
thermore, albuminuria was especially elevated in the VUR
cases, NAG is a less sensitive marker of elevated pressure
than maximum urine osmolality, and, in cases of the primary
hydronephrosis, kidney function was rarely altered.74
Dilatation of pyelocalix is a morphological abnormality
(renal pelvis between 0.5 and 2 cm in diameter), that is being
increasingly diagnosed since the universal introduction of
ultrasound scans performed in utero for pregnant women.
Ectasias may be a sign of VUR or underlying obstructions but,
in most cases the cause is not identiﬁable, in such a case it
is named simple pyelectasis. Nevertheless, since it may be
expression of underlying pathology, the question is whether
all children should be studied using imaging tests that are
expensive, not free of risk, and exposition to radiation. In
a prospective study in which we evaluated 79 children with
pyelectasis, 11 patients had VUR of different degrees.75 As
compared with VUR patients, the 68 children without VUR
showed a signiﬁcantly higher maximum urine osmolality,
while the albumin/creatine and NAG/creatinine ratios were
signiﬁcantly lower. The negative predictive value of the ﬁrst
two tests was 93%, which indicates that cystography may not
be necessary, in those cases with normal maximum urine
osmolality and albuminuria.75
In a longitudinal study including children with differing
grades of VUR we observed that, at the time of diagnosis, the
maximum urine osmolality was reduced in 69.5% of them61
but at the end of the follow-up period it was only present in
19.5%.76 At the beginning, the concentrating capacity defect
was related to the degree of VUR and at the end of the fol-
low up, the defect in concentration was related to the loss of
parenchyma rather than the initial degree of VUR. As for albu-
minuria, there were no differences between the beginning and
the end of the follow-up (19.6% vs. 17.6%). No correlation was
observed between the degree of albuminuria and the intensity
of VUR. It was concluded that urinary excretion of albumin is
a preferred marker of hyperﬁltration and loss of renal mass
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in children with VUR correlated.77 As for NAG, at the time of
diagnosis it was elevated in 37% of cases; conversely, at the
end of follow up it was normal in all cases. This suggests in
these cases, urinary excretion of NAG is a moderately sensitive
marker of elevated pressure in the urinary tract.78
On  the  speciﬁc  case  of  vesicoureteral  reﬂux  in
children  who  have  urinary  tract  infections.  An
algorithm  based  on  the  basic  tests  of  kidney
function.  Epilogue
The indication of voiding cystourethrography in series (VCUG)
has varied over the years. For a long time it was thought that
it should be ordered in all cases of UTI, especially in young
children, and especially in males.79 This was motivated by the
untrue belief that the cure of VUR, no matter its grade, would
prevent the onset of new cases of UTI and secondary kidney
damage. However this strategy has been a matter of debate
because of the following reasons1–3,5,83: many  cases of VUR
heal spontaneously with time,80,81 low degree of VUR do not
alter kidney function,76 and VUR is not the ﬁnal cause of the
UTIs82. One of the key questions on this topic is: Would there
be any problems if low-intensity VUR is not diagnosed? We
believe that the answer is “no”, because what is truly impor-
tant is the quality and quantity of existing renal parenchyma
and ensuring that kidney function is undamaged, using the
most sensitive methods mentioned in this review. As indicated
above, many  cases of mild urinary tract dilation are not asso-
ciated with VUR and, if they are, it is usually mild. The end
result is that in both circumstances (UTI and ectasias), many
VCUGs are normal and, therefore, unnecessary. We wanted to
prove whether the combination of ultrasound tests and sensi-
tive function tests could acceptably predict that the VCUG will
be negative and, therefore, prevent it from being ordered.84 We
thus collected ultrasound results and functional tests from 100
Simple pyelectasis
pelvis 0.5-2 cm with 
associated ultras
abnormalities*), w
without a history o
Basic kidney function
tests
Urinary tract infection
(UTI) with normal
renal ultrasound
Periodically repeat the basic
kidney function tests
AbnormalNormal
*Renal scarring, renal atrophy or hypodysplasia, ureter
**Preferably, cystography
Fig. 6 – Proposed algorithm for ordering cystography in children 
morphological data and basic kidney function tests.;3 6(3):222–231
children with a normal VCUG and from 63 diagnosed with VUR
(10 mild grade [I–II], 26 moderate [III], and 27 severe [IV–V]). The
most sensitive morphological abnormalities for suspecting
VUR were renal scarring, atrophic or hypodysplastic kidneys,
hydronephrosis, and pyelolalix ectasia associated with other
morphological abnormalities. In terms of kidney function,
statistically signiﬁcant differences (p = 0.004) were shown by
comparing maximum urine osmolality in children with or
without VUR. The urinary excretion values of albumin and
NAG were not sensitive, but very speciﬁc (87.9%) in the VUR
cases. Combining the morphological and function parameters,
70% of children with mild VUR, 76.9% of those with moderate
VUR, and 100% with severe VUR had morphological or func-
tion abnormalities. Thus, the highest negative predictive value
(80.8%) for detecting VUR was obtained by combining mor-
phological abnormalities, excluding simple pyelectasis, those
who only had kidney functional abnormalities, and those
with both functional and morphological alterations (116/163).
Moreover, in those cases, the sensitivity for diagnosing VUR
was 85.7%. Our conclusion is simple: if kidney function is nor-
mal, especially the concentrating capacity, and if there are no
morphological abnormalities other than pyelectasis, the use
of VCUG is not initially indicated. (Fig. 6). It is necessary to
emphasize that, in the case of recent pyelonephritis, the tests
should be performed after 2 and 4 month in order to avoid
artefact in the results.
In summary, the appropriate use of the basic kidney func-
tion tests offers the possibility of changing the strategy of
ordering imaging tests in routine clinical practice in children
with loss of renal parenchyma or urinary tract dilation. The
renal concentration mechanism is so complex that any abnor-
mality has repercussions on the maximum urine osmolality;
as mentioned above, it is the ﬁrst functional abnormality
detected in many  kidney disorders. Thus, in the absence of
hydronephrosis, in children with UTI or ectasia of pyelocalix,
ordering VCUG or nuclear medicine tests could be put off
 (renal
no other
ound
ith or
f UTI
Cystography**
Renal pelvis >2 cm or <2 cm with
other associated morphological
abnormalities*, with or without a
history of UTI
al dilation, or ureterocele
with UTI or CAKUT based on speciﬁc ultrasound
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nitially if the maximum urine osmolality and urinary excre-
ion of albumin are normal. Conversely, abnormal kidney
unction would require further tests so the origin of these
bnormalities is identiﬁed.
As written by Maran˜ón in his Crítica de la Medicina dogmática
1950): “I want to tell to those working close to me, never for-
et that each thing that doctors know should be known as
recisely as possible, but being aware that its value may be
emporal.”
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